British Journal of Sexual Medicine

Reference list

Abel P, Ockrim J. Feedback – Bone health in men with prostate cancer. BJSM 2008; 31.4: 11.

1. Rajpal S, Brown S. Optimising bone health in men with prostate cancer. British Journal of Sexual Medicine 2008; 30(4): 10–12.

2. Walsh PC, DeWeese TL, Eisenberger MA. A structured debate: immediate versus deferred androgen suppression in prostate cancer – evidence for deferred treatment. J Urol 2001; 166: 508–515.

3. Hedlund PO, Ala-Opas M, Brekkan E et al; Scandinavian Prostatic Cancer Group. Parenteral estrogen versus combined androgen deprivation in the treatment of metastatic prostatic cancer – Scandinavian Prostatic Cancer Group (SPCG) Study No. 5. Scand J Urol Nephrol 2002; 36: 405–413.

4. Ockrim J, Lalani el-N, Abel P. Therapy Insight: parenteral estrogen treatment for prostate cancer – a new dawn for an old therapy. Nat Clin Pract Oncol 2006; 3: 552–563.

5. PR09: PATCH (Prostate Adenocarcinoma: TransCutaneous Hormones) A randomised controlled trial of transcutaneous oestrogen patches versus luteinising hormone releasing hormone analogues in prostate cancer. http://www.ctu.mrc.ac.uk/studies/PR09.asp (last accessed 02/12/08)

Published by Hayward Medical Communications

www.hayward.co.uk